Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec;53(12):1666-1668.
doi: 10.1016/j.dld.2021.08.006. Epub 2021 Aug 30.

Returning to endoscopy normality through the support of a new non-invasive faecal test based on microbial signatures

M Malagón  1 , L Oliver  1 , S Ramió-Pujol  1 , J Guardiola  2 , F Balaguer  3
Affiliations
Comment

Returning to endoscopy normality through the support of a new non-invasive faecal test based on microbial signatures

M Malagón et al. Dig Liver Dis. 2021 Dec.
No abstract available

Keywords: Bacterial markers; COVID-19; Colorectal cancer screening; Faecal immunochemical test; Intestinal microbiota; in vitro diagnosis; qPCR.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest Dr. Ramió-Pujol, Mrs. Oliver, and Dr. Malagón are employees from GoodGut, company who has received private and public funding. Dr. Ramió-Pujol, Ms. Oliver, and Dr. Malagón report grants from MINECO and from CDTI, during the conduct of the study. Dr. Ramió-Pujol and Dr. Malagón have a licensed patent to GoodGut: PCT/EP2020/056575. Dr. Balaguer received an honorarium for consultancy from Sysmex, Cancer Prevention Pharmaceuticals, speaker's fees from Norgine, and editorial fee from Elsevier. The rest of the authors have nothing to disclose.

Comment on

References

    1. Julie M. Vose. Delay in cancer screening and diagnosis during the COVID-19 pandemic: What is the cost? vol. 34. 2020. 10.46883/ONC.2020.3409.0358. - PubMed
    1. Gralnek I.M., Hassan C., Dinis-Ribeiro M. COVID-19 and endoscopy: implications for healthcare and digestive cancer screening. Nat Rev Gastroenterol Hepatol. 2020;17:444–446. doi: 10.1038/s41575-020-0312-x. - DOI - PMC - PubMed
    1. Buscarini E., Benedetti A., Monica F., Pasquale L., Buttitta F., Cameletti M., et al. Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: A nationwide survey. Dig Liver Dis. 2021;53:682–688. doi: 10.1016/j.dld.2021.02.021. - DOI - PubMed
    1. Kaufman H.W., Chen Z., Niles J., Fesko Y. Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic. JAMA Netw Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.17267. - DOI - PMC - PubMed
    1. Maringe C., Spicer J., Morris M., Purushotham A., Nolte E., Sullivan R., et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21:1023–1034. doi: 10.1016/S1470-2045(20)30388-0. - DOI - PMC - PubMed

LinkOut - more resources